Investor Centre

Summit is publicly listed in the US (NASDAQ)

News

Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer
VIEW NEWS
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020
VIEW NEWS